Global Ultrasonic Nebulizer Market Trends

• Portable and homecare oriented designs: Key manufacturers are launching innovative portable and compact designs of ultrasonic nebulizers aligned with the growing trend of home healthcare and self-administration. These new portable models are lightweight, noiseless, and fast while ensuring optimized drug delivery. For example, Omron’s pocket-sized Mesh Nebulizer NE-SM1 enables easy self-administration of asthma medication at home. The trend of portable, handheld nebulizers suitable for home use is expected to shape technological innovation and product development in the ultrasonic nebulizer market.
• Growing adoption of mesh nebulizer technology: Mesh nebulizers that use vibrating mesh/aperture plate technology are gaining increasing popularity owing to their higher efficiency and faster nebulization. Mesh nebulizers produce fine mist with a consistent particle size for improved lung deposition and can nebulize drug solutions rapidly within minutes. This improves patient convenience and outcomes. Companies like Omron, PARI Pharma, and Aerogen have introduced innovative ultrasonic mesh nebulizers. The growing adoption of this technology will be a key trend shaping product launches and advancements in the market.
• Wireless and portable ultrasonic nebulizers: The trend of wireless and portable ultrasonic nebulizers is having a significant impact on the global ultrasonic nebulizer market. As lifestyles become increasingly mobile and fast-paced, consumers are demanding medical devices that can easily accommodate active lifestyles without compromising on treatment. Wireless and portable nebulizers address this need perfectly by allowing users freedom of movement during use. As these devices do not require passengers or adapters for power, they provide maximum mobility and are easy to carry around. This flexibility is proving extremely appealing to users.
• Increasing adoption of organic growth strategies such as product approvals: Increasing adoption of organic growth strategies, such as product approvals by regulatory bodies, is expected to drive the growth of the market over the forecast period. For instance, in March 2021, PARI Pharma GmbH, a company focused on advanced aerosol delivery systems based on eFlow Technology, announced the authorization of the LAMIRA Nebulizer System for delivery of Insmed, Inc., a biopharmaceutical company’s drug product ARIKAYCE (amikacin liposome inhalation suspension) in Japan. The LAMIRA Nebulizer System is specifically optimized for ARIKAYCE and therefore the only device intended to administer it.

Ultrasonic Nebulizer Market Regional Insights

• North America is expected to be the largest market for global ultrasonic nebulizer market during the forecast period, accounting for over 41.3% of the market share in 2023. The growth of the market in North America is attributed to the high prevalence of respiratory diseases, presence of key players, and favorable reimbursement policies in the region.
• The Europe market is expected to be the second-largest market for global ultrasonic nebulizer market, accounting for over 26.1% of the market share in 2023. The growth of the market in is attributed to the rising geriatric population and investments in research and development activities in the region.
• The Asia Pacific market is expected to be the fastest-growing market for global ultrasonic nebulizer market, with a CAGR of over 20.3% during the forecast period. The growth of the market in Asia Pacific is attributed to the growing healthcare expenditure and increasing adoption of home healthcare products in the region.

Figure 1. Global Ultrasonic Nebulizer Market Share (%), by Region, 2023